Drugs / Flu-M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05312294 | Dec 2020 → Sep 2021 | influenza | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flu-M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05312294 ↗ |
| Modality | Vaccine | “inactivated split influenza vaccine” NCT05312294 ↗ |
| Route | Intramuscular | “intramuscularly” NCT05312294 ↗ |